PROFILE - Geert Hertecant: "intelligent materials are the future of biologics"
This article was originally published in Clinica
Executive Summary
Having served at Medtronic for 18 years and then at Medtronic's Kyphon for three years, what inspired Geert to make the move to ApaTech? "At Kyphon, I helped to introduce balloon kyphoplasty to the market. This fed my passion to undertake market development with niche products - I am highly motivated to bring new technologies to the market," he said. ApaTech - the “fastest growing UK medtech firm - and fifth-fastest growing technology firm in the UK” (according to the Tech Track 100 league table) - "offers me the opportunity to build a unique portfolio of products within a market segment that offers growth potential for innovative products", he said.
You may also be interested in...
Asia Regulatory Forum Update
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia adopts interim device authorisation regulation
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
Canada takes action to increase more adverse event reporting
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.